Discover open access scientific publications

Search, annotate, share and cite publications

Publications by H. J. M. A. A. Zijlmans

Efficacy of PD-1 Blockade in Cervical Cancer Is Related to a CD8+FoxP3+CD25+ T-Cell Subset With Operational Effector Functions Despite High Immune Checkpoint Levels

Journal for ImmunoTherapy of Cancer

English

Related publications

PD-1 and PD-L1 Immune Checkpoint Blockade to Treat Breast Cancer

English

Presence of Suppressor HIV-Specific CD8+ T Cells Is Associated With Increased PD-1 Expression on Effector CD8+ T Cells

Journal of Immunology

Allergy

Immunology

2008

English

Current Understanding of the Mechanisms Underlying Immune Evasion From PD-1/PD-L1 Immune Checkpoint Blockade in Head and Neck Cancer

Frontiers in Oncology

Cancer Research

Oncology

2020

English

P2.04-04 Expression of Intratumoral Programmed Cell Death-Ligand 1 (PD-L1) and Intratumoral CD4+T Cell, CD8+T Cell and FOXP3+T Cell in Lung Cancer

Journal of Thoracic Oncology

English

The Therapeutic Promise of Disrupting the PD-1/PD-L1 Immune Checkpoint in Cancer: Unleashing the CD8 T Cell Mediated Anti-Tumor Activity Results in Significant, Unprecedented Clinical Efficacy in Various Solid Tumors

Journal for ImmunoTherapy of Cancer

English

Intratumoral Tcf1+PD-1+cd8+ T Cells With Stem-Like Properties Promote Tumor Control in Response to Vaccination and Checkpoint Blockade Immunotherapy

English

Pd-1 Immune Checkpoint Blockade Improves Anti-Cd20 Based Immunotherapy in Follicular Lymphoma

Hematological Oncology

English

MA11.01 Comparative Efficacy of T-Cell Intrinsic Versus Extrinsic PD-1 Blockade to Overcome PD-L1+ Tumor-Mediated Exhaustion

Journal of Thoracic Oncology

English

Virus-Specific CD8+ T Cells Infiltrate Melanoma Lesions and Retain Function Despite High PD-1 Expression

Journal for ImmunoTherapy of Cancer

English

Amanote Research

Discover open access scientific publications

Search, annotate, share and cite publications

Publications by H. J. M. A. A. Zijlmans

Efficacy of PD-1 Blockade in Cervical Cancer Is Related to a CD8+FoxP3+CD25+ T-Cell Subset With Operational Effector Functions Despite High Immune Checkpoint Levels

Related publications

PD-1 and PD-L1 Immune Checkpoint Blockade to Treat Breast Cancer

Presence of Suppressor HIV-Specific CD8+ T Cells Is Associated With Increased PD-1 Expression on Effector CD8+ T Cells

Current Understanding of the Mechanisms Underlying Immune Evasion From PD-1/PD-L1 Immune Checkpoint Blockade in Head and Neck Cancer

P2.04-04 Expression of Intratumoral Programmed Cell Death-Ligand 1 (PD-L1) and Intratumoral CD4+T Cell, CD8+T Cell and FOXP3+T Cell in Lung Cancer

The Therapeutic Promise of Disrupting the PD-1/PD-L1 Immune Checkpoint in Cancer: Unleashing the CD8 T Cell Mediated Anti-Tumor Activity Results in Significant, Unprecedented Clinical Efficacy in Various Solid Tumors

Intratumoral Tcf1+PD-1+cd8+ T Cells With Stem-Like Properties Promote Tumor Control in Response to Vaccination and Checkpoint Blockade Immunotherapy

Pd-1 Immune Checkpoint Blockade Improves Anti-Cd20 Based Immunotherapy in Follicular Lymphoma

MA11.01 Comparative Efficacy of T-Cell Intrinsic Versus Extrinsic PD-1 Blockade to Overcome PD-L1+ Tumor-Mediated Exhaustion

Virus-Specific CD8+ T Cells Infiltrate Melanoma Lesions and Retain Function Despite High PD-1 Expression